Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

Substance abuse in schizophrenia: a review.

Buckley PF.

J Clin Psychiatry. 1998;59 Suppl 3:26-30. Review.

2.

Schizophrenia and comorbid substance use disorder: effects of antipsychotics.

Green AI.

J Clin Psychiatry. 2005;66 Suppl 6:21-6. Review.

3.
4.

Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches.

Green AI.

J Clin Psychiatry. 2006;67 Suppl 7:31-5; quiz 36-7. Review.

5.

Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders.

San L, Arranz B, Martinez-Raga J.

Eur Addict Res. 2007;13(4):230-43. Review.

PMID:
17851245
6.

Clozapine treatment in patients with prior substance abuse.

Kelly DL, Gale EA, Conley RR.

Can J Psychiatry. 2003 Mar;48(2):111-4.

PMID:
12655909
7.

[Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].

Wobrock T, D'Amelio R, Falkai P.

Nervenarzt. 2008 Jan;79(1):17-8, 20-2, 24-6 passim. Review. German.

PMID:
17619840
8.

Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey.

Zimmet SV, Strous RD, Burgess ES, Kohnstamm S, Green AI.

J Clin Psychopharmacol. 2000 Feb;20(1):94-8.

PMID:
10653215
9.

The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia.

Drake RE, Xie H, McHugo GJ, Green AI.

Schizophr Bull. 2000;26(2):441-9.

10.

New antipsychotic agents: emerging clinical profiles.

Buckley PF.

J Clin Psychiatry. 1999;60 Suppl 1:12-7; discussion 28-30. Review.

11.

Reduction of comorbid substance abuse with clozapine.

Marcus P, Snyder R.

Am J Psychiatry. 1995 Jun;152(6):959. No abstract available.

PMID:
7755141
12.

Treatment of schizophrenia and comorbid substance use disorder.

Green AI, Salomon MS, Brenner MJ, Rawlins K.

Curr Drug Targets CNS Neurol Disord. 2002 Apr;1(2):129-39. Review.

PMID:
12769622
13.

Substance abuse and the management of medication nonadherence in schizophrenia.

Wilk J, Marcus SC, West J, Countis L, Hall R, Regier DA, Olfson M.

J Nerv Ment Dis. 2006 Jun;194(6):454-7.

PMID:
16772865
14.

Clozapine use in a forensic population in a New South Wales prison hospital.

Martin A, O'Driscoll C, Samuels A.

Aust N Z J Psychiatry. 2008 Feb;42(2):141-6. doi: 10.1080/00048670701787529.

PMID:
18197509
15.
16.

Clozapine for substance-abusing schizophrenic patients.

Tsuang JW, Eckman TE, Shaner A, Marder SR.

Am J Psychiatry. 1999 Jul;156(7):1119-20. No abstract available.

PMID:
10401473
17.

Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.

Potvin S, Stip E, Lipp O, Roy MA, Demers MF, Bouchard RH, Gendron A.

Am J Drug Alcohol Abuse. 2008;34(1):75-82.

PMID:
18161645
18.

[Schizophrenia and addiction: An evaluation of the self-medication hypothesis].

Potvin S, Stip E, Roy JY.

Encephale. 2003 May-Jun;29(3 Pt 1):193-203. Review. French.

PMID:
12876543
19.

[Treatment of schizophrenia in subjects with substance use disorders: A review].

Rubio Valladolid G, Casas Brugué M.

Actas Esp Psiquiatr. 2001 Mar-Apr;29(2):124-30. Review. Spanish.

PMID:
11333531
20.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
Items per page

Supplemental Content

Write to the Help Desk